Repolarization Vulnerability is Rarely Observed in COVID-19 Patients With Low Comorbidity Treated with A Combination of Hydroxychloroquine Azithromycin

Authors

David Goldgrab, HCA HealthcareFollow
Sokol Kalaveshi, HCA HealthcareFollow
Ruifang Yang MD, HCA HealthcareFollow
Jearim Craig
Mauricio Gomez, HCA HealthcareFollow
Stephen Mester, HCA HealthcareFollow
Christian Perzanowski, HCA HealthcareFollow

Preview

Division

West Florida

Hospital

Brandon Regional Hospital

Specialty

Cardiology

Document Type

Image

Publication Date

2021

Keywords

QTC, COVID, hydroxychloroquine, azithromycin

Disciplines

Cardiology | Cardiovascular Diseases | Virus Diseases

Original Publisher

HCA Healthcare Graduate Medical Education

Recommended Citation

Goldgrab, David; Kalaveshi, Sokol; Yang, Ruifang MD; Craig, Jearim; Gomez, Mauricio; Mester, Stephen; and Perzanowski, Christian, "Repolarization Vulnerability is Rarely Observed in COVID-19 Patients With Low Comorbidity Treated with A Combination of Hydroxychloroquine Azithromycin" (2021). West Florida Division GME Research Day 2021. 23.
https://scholarlycommons.hcahealthcare.com/westflorida2021/23